Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Zakaria Einbeigi

Läkare

Zakaria Einbeigi
Läkare
Cancergenetik. Sarkom
zakaria.einbeigi@oncology.gu.se
0 31-342 1000

Postadress: Jubileumskliniken, Sahlgrenska universitetssjukhuset, 413 45 Göteborg
Besöksadress: Jubileumskliniken, Sahlgrenska universitetssjukhuset, Blå stråket 2 , Göteborg


Avd för onkologi vid Institutionen för kliniska vetenskaper (Mer information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
0313428503
Besöksadress: Blå stråket 2 SU/Jubileusklin , 413 45 Göteborg

Senaste publikationer

Breast cancer survival trends in different stages and age groups - a population-based study 1989-2013.
Anna Nordenskjöld, Helena Fohlin, Lars G Arnesson, Zakaria Einbeigi, Erik Holmberg et al.
Acta oncologica (Stockholm, Sweden), Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer.
Siker Kimbung, Ida Johansson, Anna Danielsson, Srinivas Veerla, Suzanne Egyhazi Brage et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Artikel i vetenskaplig tidskrift 2016
Artikel i vetenskaplig tidskrift

No clear effect of postoperative radiotherapy on survival of breast cancer patients with 1-3 positive nodes: A population-based study.
Anna Nordenskjöld, H I Fohlin, Per Albertsson, L G Arnesson, C Chamalidou et al.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.
Siker Kimbung, Anikó Kovács, Anna Danielsson, Pär-Ola Bendahl, Kristina Lövgren et al.
Oncotarget, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival.
N P Tobin, J C Harrell, J Lövrot, S Egyhazi Brage, M Frostvik Stolt et al.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

32p * biomarkers and molecular subtypes in primary breast tumors and metastases: associations with liver metastases and outcome.
S Kimbung, Anikó Kovács, I Johansson, Anna Danielsson, P Bendahl et al.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Artikel i vetenskaplig tidskrift 2014
Artikel i vetenskaplig tidskrift

Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer.
L S Lindström, J Li, M Lee, Zakaria Einbeigi, M Hartman et al.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Artikel i vetenskaplig tidskrift 2014
Artikel i vetenskaplig tidskrift

Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel.
Barbro Linderholm, E Lidbrink, E Tallroth, Zakaria Einbeigi, H Svensson et al.
Breast (Edinburgh, Scotland), Artikel i vetenskaplig tidskrift 2013
Artikel i vetenskaplig tidskrift

Visar 21 - 30 av 44

2012

Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.
Tomas Kirchhoff, Mia M Gaudet, Antonis C Antoniou, Lesley McGuffog, Manjeet K Humphreys et al.
PloS one, Artikel i vetenskaplig tidskrift 2012
Artikel i vetenskaplig tidskrift

2011

Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Anna Marie Mulligan, Fergus J Couch, Daniel Barrowdale, Susan M Domchek, Diana Eccles et al.
Breast cancer research : BCR, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
David G Cox, Jacques Simard, Daniel Sinnett, Yosr Hamdi, Penny Soucy et al.
Human molecular genetics, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
Amanda B Spurdle, Louise Marquart, Lesley McGuffog, Sue Healey, Olga Sinilnikova et al.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.
A Osorio, R L Milne, R Alonso, G Pita, P Peterlongo et al.
British journal of cancer, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Kate M Im, Tomas Kirchhoff, Xianshu Wang, Todd Green, Clement Y Chow et al.
Human genetics, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Antonis C Antoniou, Christiana Kartsonaki, Olga M Sinilnikova, Penny Soucy, Lesley McGuffog et al.
Human molecular genetics, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients.
I E Smith, J-Y Pierga, L Biganzoli, H Cortés-Funes, C Thomssen et al.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

Visar 21 - 30 av 44

Sidansvarig: Katarina Olinder Eriksson|Sidan uppdaterades: 2013-03-28
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?